Medtronic (MDT)

Medtronic on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, federal contracts, earnings dates and insider trades. Listed on NYSE, classified by the SEC as electromedical & electrotherapeutic apparatus.

Download CSV

40.0M

Short interest

settlement 2026-09-30

2.7

Days to cover

+0.8 days vs prior

73.4%

Short share of volume

2026-10-09

26,309

Fails to deliver

settlement 2026-09-11

Tue 17 Nov

Next earnings

estimated date

-$139K

Insider flow, 90 days

0 buys, 1 sells

As of 2026-10-09.

Short interest

FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in MDT is 39,974,230 shares, up 27,839,719 shares over the last month. Over the last 48 readings it ranged from 7,884,485 shares (30 May 2025) to 39,974,230 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 14.7M shares a day that is 2.7 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/mdt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-09-30	39,974,230	+132.0%	14,671,374	2.72
2026-09-15	17,229,743	+42.0%	8,728,936	1.97
2026-08-31	12,134,511	-15.4%	7,257,442	1.67
2026-08-14	14,350,429	-20.8%	6,383,199	2.25
2026-07-31	18,120,230	-4.8%	7,644,594	2.37
2026-07-15	19,025,990	-0.3%	7,779,714	2.45
2026-06-30	19,087,345	+3.6%	11,024,060	1.73
2026-06-15	18,431,994	+10.0%	12,159,839	1.52
2026-05-29	16,762,517	+14.4%	11,263,371	1.49
2026-05-15	14,645,842	+0.3%	9,882,933	1.48
2026-04-30	14,604,547	-5.5%	9,708,099	1.50
2026-04-15	15,456,314	-9.0%	7,498,223	2.06
2026-03-31	16,984,763	+2.4%	8,205,424	2.07
2026-03-13	16,594,287	+7.6%	8,639,240	1.92
2026-02-27	15,426,378	-11.0%	9,047,389	1.71
2026-02-13	17,328,251	-12.1%	9,509,623	1.82
2026-01-30	19,723,625	+17.6%	8,978,904	2.20
2026-01-15	16,774,153	+16.5%	6,868,763	2.44
2025-12-31	14,397,372	-4.8%	5,453,596	2.64
2025-12-15	15,131,648	-20.3%	6,098,112	2.48
2025-11-28	18,974,699	+40.2%	10,540,864	1.80
2025-11-14	13,532,095	-6.2%	6,255,699	2.16
2025-10-31	14,431,402	-3.5%	5,745,781	2.51
2025-10-15	14,948,934	+40.2%	6,945,056	2.15

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 9 October 2026, the short share of MDT volume is 73.4%, up 6.5 points over the last five sessions. Over the last 30 readings it ranged from 26.1% (22 September 2026) to 84.9% (5 October 2026). The latest reading is 24.4 points above the 30-session average of 49.0%, on 10.2M shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-10-09	7.5M	10.2M	73.4%	836
2026-10-08	14.2M	19.2M	73.6%	10,411
2026-10-07	8.6M	16.3M	53.0%	18,164
2026-10-06	13.1M	18.4M	71.2%	14,519
2026-10-05	15.2M	17.9M	84.9%	15,698
2026-10-02	5.8M	8.7M	66.9%	11,302
2026-10-01	2.2M	5.2M	43.5%	11,285
2026-09-30	3.5M	6.1M	57.6%	2,814
2026-09-29	2.1M	6.2M	34.4%	22,500
2026-09-28	5.9M	8.6M	68.5%	12,830
2026-09-25	2.3M	4.8M	48.5%	13,546
2026-09-24	2.2M	4.1M	52.5%	11,559
2026-09-23	1.7M	4.0M	43.4%	14,967
2026-09-22	1.3M	5.0M	26.1%	13,814
2026-09-21	1.2M	2.7M	43.3%	2,180
2026-09-18	1.0M	2.6M	39.5%	5,690
2026-09-17	1.6M	3.0M	51.8%	11,885
2026-09-16	1.3M	2.5M	51.4%	2,093
2026-09-15	1.2M	2.4M	49.2%	2,277
2026-09-14	1.2M	3.4M	36.9%	4,161
2026-09-11	897K	2.1M	43.4%	1,490
2026-09-10	870K	2.0M	42.7%	11,638
2026-09-09	708K	2.3M	31.0%	1,307
2026-09-08	1.1M	2.9M	39.7%	1,000
2026-09-04	1.5M	3.3M	46.5%	975
2026-09-03	1.4M	2.8M	47.5%	1,126
2026-09-02	1.7M	3.6M	45.5%	6,422
2026-09-01	3.0M	7.8M	38.3%	2,393
2026-08-31	1.2M	3.4M	34.1%	5,374
2026-08-28	705K	2.2M	32.6%	7,886

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 11 September 2026, the fails-to-deliver balance in MDT is 26,309 shares, up 26,109 shares over the last settlement date. Over the last 30 readings it ranged from 8 shares (15 July 2026) to 345,617 shares (8 June 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-09-11	26,309	$91.62	$2.4M
2026-09-09	200	$92.39	$18K
2026-09-01	5,498	$90.65	$498K
2026-08-24	1,664	$93.35	$155K
2026-08-11	326	$89.41	$29K
2026-08-04	1,320	$86.68	$114K
2026-07-31	3,613	$85.71	$310K
2026-07-30	204	$87.54	$18K
2026-07-24	989	$82.01	$81K
2026-07-23	122	$81.89	$10K
2026-07-17	50	$83.56	$4K
2026-07-15	8	$79.30	$634
2026-07-10	58	$82.39	$5K
2026-07-07	818	$83.06	$68K
2026-07-06	1,792	$83.19	$149K
2026-07-01	126	$78.23	$10K
2026-06-30	199	$80.93	$16K
2026-06-29	200	$80.98	$16K
2026-06-25	6,792	$80.13	$544K
2026-06-22	200	$79.34	$16K
2026-06-15	3,918	$80.20	$314K
2026-06-08	345,617	$81.67	$28.2M
2026-06-01	21	$73.81	$2K
2026-05-29	17,116	$75.57	$1.3M
2026-05-26	300	$78.60	$24K
2026-05-22	2,605	$78.15	$204K
2026-05-15	85	$76.97	$7K
2026-04-22	13	$82.00	$1K
2026-04-15	9	$88.12	$793
2026-04-10	10,506	$87.91	$924K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

Insiders at MDT reported 1 open-market sell worth $139K in the last 90 days and no open-market buys. Latest filing: KIIL HARRY SKIP (EVP & President Cardiovascular) on 2026-09-16.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-09-16	KIIL HARRY SKIP	EVP & President Cardiovascular	Sell	1K	$93.65	$139K	42K
2026-09-15	Blomquist Denise L.	Chief Accounting Officer	Gift	600	$0.00	$0	16K
2026-08-20	Marinaro Michael	EVP, Pres MedSurg and Americas	Tax withholding	1K	$92.30	$100K	116K
2026-08-03	Thompson Kweli	EVP & President, Neuroscience	Grant	7K	$0.00	$0	35K
2026-08-03	Pieton Thierry	EVP & Chief Financial Officer	Grant	12K	$0.00	$0	50K
2026-08-03	Walter Matthew R.	SVP, Chief HR Officer	Grant	6K	$0.00	$0	40K
2026-08-03	Quinn Michelle	EVP, GC and Secretary	Grant	6K	$0.00	$0	27K
2026-08-03	Martha Geoffrey	Chairman and CEO	Grant	42K	$0.00	$0	328K
2026-08-03	Marinaro Michael	EVP, Pres MedSurg and Americas	Grant	46K	$0.00	$0	117K
2026-08-03	Marinaro Michael	EVP, Pres MedSurg and Americas	Grant	11K	$0.00	$0	71K
2026-08-03	KIIL HARRY SKIP	EVP & President Cardiovascular	Grant	9K	$0.00	$0	44K
2026-08-03	Blomquist Denise L.	Chief Accounting Officer	Grant	2K	$0.00	$0	17K
2026-07-31	Thompson Kweli	EVP & President, Neuroscience	Tax withholding	2K	$85.39	$148K	28K
2026-07-31	Walter Matthew R.	SVP, Chief HR Officer	Tax withholding	2K	$85.39	$143K	34K
2026-07-31	Martha Geoffrey	Chairman and CEO	Tax withholding	16K	$85.39	$1.4M	286K
2026-07-31	Marinaro Michael	EVP, Pres MedSurg and Americas	Tax withholding	3K	$85.39	$287K	60K
2026-07-31	KIIL HARRY SKIP	EVP & President Cardiovascular	Tax withholding	3K	$85.39	$262K	34K
2026-07-31	Blomquist Denise L.	Chief Accounting Officer	Tax withholding	212	$85.39	$18K	15K
2026-07-28	Quinn Michelle	EVP, GC and Secretary	Tax withholding	2K	$86.88	$180K	20K
2026-07-08	Walter Matthew R.	SVP, Chief HR Officer	Sell	3K	$83.15	$258K	36K
2026-06-08	KIIL HARRY SKIP	EVP & President Cardiovascular	Sell	228	$80.45	$18K	37K
2026-06-08	KIIL HARRY SKIP	EVP & President Cardiovascular	Sell	4K	$80.44	$319K	37K
2026-06-05	Blomquist Denise L.	Chief Accounting Officer	Tax withholding	237	$83.32	$20K	15K
2026-06-04	Walter Matthew R.	SVP, Chief HR Officer	Tax withholding	3K	$83.32	$237K	39K
2026-06-04	Martha Geoffrey	Chairman and CEO	Tax withholding	42K	$83.32	$3.5M	301K
2026-06-04	Marinaro Michael	EVP, Pres MedSurg and Americas	Tax withholding	7K	$83.32	$622K	63K
2026-06-04	KIIL HARRY SKIP	EVP & President Cardiovascular	Tax withholding	7K	$83.32	$568K	41K
2026-05-26	Walter Matthew R.	SVP, Chief HR Officer	Option exercise	9K	$0.00	$0	42K
2026-05-26	Wall Brett A.	EVP & Pres Neuroscience	Option exercise	27K	$0.00	$0	82K
2026-05-26	Martha Geoffrey	Chairman and CEO	Option exercise	95K	$0.00	$0	343K
2026-05-26	Marinaro Michael	EVP, Pres MedSurg and Americas	Option exercise	19K	$0.00	$0	71K
2026-05-26	KIIL HARRY SKIP	EVP & President Cardiovascular	Option exercise	15K	$0.00	$0	48K
2026-05-26	Blomquist Denise L.	Chief Accounting Officer	Option exercise	2K	$0.00	$0	15K
2026-05-01	Walter Matthew R.	SVP, Chief HR Officer	Tax withholding	35	$80.00	$3K	32K
2026-04-28	NABEL ELIZABETH G	Director	Tax withholding	207	$81.90	$17K	20K
2026-04-28	Powell Kendall J	Director	Tax withholding	207	$81.90	$17K	51K
2026-04-28	Lofton Kevin E	Director	Tax withholding	207	$81.90	$17K	10K
2026-04-28	Lewis Gregory P	Director	Tax withholding	207	$81.90	$17K	6K
2026-04-28	HOGAN RANDALL J	Director	Tax withholding	207	$81.90	$17K	49K
2026-04-28	Fonseca Lidia	Director	Tax withholding	207	$81.90	$17K	8K
2026-04-28	DONNELLY SCOTT C	Director	Tax withholding	207	$81.90	$17K	24K
2026-04-28	Blomquist Denise L.	Chief Accounting Officer	Tax withholding	318	$81.90	$26K	13K
2026-04-28	ARNOLD CRAIG	Director	Tax withholding	207	$81.90	$17K	42K
2026-04-27	NABEL ELIZABETH G	Director	Grant	2K	$0.00	$0	20K
2026-04-27	Powell Kendall J	Director	Grant	2K	$0.00	$0	52K
2026-04-27	Lofton Kevin E	Director	Grant	2K	$0.00	$0	10K
2026-04-27	Lewis Gregory P	Director	Grant	2K	$0.00	$0	6K
2026-04-27	Lee Joon Sup	Director	Grant	2K	$0.00	$0	2K
2026-04-27	Jellison William R	Director	Grant	1K	$0.00	$0	6K
2026-04-27	HOGAN RANDALL J	Director	Grant	2K	$0.00	$0	49K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

5 Form 144 notices on file for MDT worth $8.9M at the prices reported; 1 in the last 90 days worth $139K. Latest: KIIL HARRY SKIP filed on 2026-09-16 to sell 1,483 shares ($139K) from 2026-09-16.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-09-16	KIIL HARRY SKIPOfficer	1K	$139K	0.000%	2026-09-16	Fidelity Brokerage Services LLC
2026-07-08	Walter Matthew R.Officer	3K	$258K	0.000%	2026-07-08	Fidelity Brokerage Services LLC
2026-06-08	KIIL HARRY SKIPOfficer	4K	$337K	0.000%	2026-06-08	Fidelity Brokerage Services LLC
2026-02-19	KIIL HARRY SKIPOfficer	53K	$5.1M	0.004%	2026-02-19	Fidelity Brokerage Services LLC
2025-11-19	Smith Gregory LOfficer	30K	$3.1M	0.002%	2025-11-19	Fidelity Brokerage Services LLC

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

1 holder reports 5% or more of MDT in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (96,424,044 shares), filed 2026-04-28 for an event on 2026-03-31.

Filed	Form	Holder	Shares	Of class	Event
2026-04-28	13G	Vanguard Capital Managementinvestment adviser	96.4M	7.5%	2026-03-31
2026-03-27	13G/Ano. 10	The Vanguard Groupinvestment adviser	0	0.0%	2026-03-13

13F holders

Tracked managers holding MDT at their latest 13F. JSON

8 of the 30 tracked managers held MDT at their latest 13F, $1.64B in total at quarter-end prices. Citadel Advisors is the largest at $420.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 7 added shares and 1 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Citadel Advisors	2026-06-30	5.4M	$420.4M	0.05%	+4.4M
D. E. Shaw & Co.	2026-06-30	4.4M	$344.0M	0.16%	+3.5M
AQR Capital Management	2026-06-30	3.3M	$258.1M	0.09%	+1.7M
Two Sigma Investments	2026-06-30	3.2M	$253.5M	0.18%	+2.6M
Renaissance Technologies	2026-06-30	3.2M	$247.8M	0.34%	new
Millennium Management	2026-06-30	918K	$71.9M	0.03%	+446K
Bridgewater Associates	2026-06-30	483K	$37.7M	0.15%	+227K
Fisher Asset Management	2026-06-30	117K	$9.2M	0.00%	-22K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q1 FY 2027 (quarter ended 2026-07-31) Medtronic reported revenue of $9.76B, up 13.7% from the same quarter a year earlier, and net income of $1.47B (1.14 diluted EPS). In FY 2026 it generated $7.33B of operating cash flow and spent $1.03B on buybacks and $3.64B on dividends. As of 2026-07-31, cash was $1.69B against $2.54B of debt.

Cash: $1.69B
Debt: $2.54B
Equity: $50.23B
Total assets: $93.31B
Shares outstanding: 1,279,137,890

Quarterly, last 8 quarters

Quarter	Period end	Revenue	Net income	Margin	Diluted EPS
Q1 FY 2027	2026-07-31	$9.76B	$1.47B	15.1%	1.14
Q4 FY 2026derived	2026-04-24	$9.81B	$1.24B	12.7%	n/a
Q3 FY 2026	2026-01-23	$9.02B	$1.14B	12.7%	0.89
Q2 FY 2026	2025-10-24	$8.96B	$1.37B	15.3%	1.07
Q1 FY 2026	2025-07-25	$8.58B	$1.04B	12.1%	0.81
Q4 FY 2025derived	2025-04-25	$8.93B	$1.06B	11.8%	n/a
Q3 FY 2025	2025-01-24	$8.29B	$1.29B	15.6%	1.01
Q2 FY 2025	2024-10-25	$8.40B	$1.27B	15.1%	0.99

Fiscal years, with buybacks and dividends

Fiscal year	Ends	Revenue	Net income	Operating cash flow	Capex	Buybacks	Dividends
FY 2026	2026-04-24	$36.36B	$4.80B	$7.33B	$1.90B	$1.03B	$3.64B
FY 2025	2025-04-25	$33.54B	$4.66B	$7.04B	$1.86B	$3.23B	$3.59B
FY 2024	2024-04-26	$32.36B	$3.68B	$6.79B	$1.59B	$2.14B	$3.67B
FY 2023	2023-04-28	$31.23B	$3.76B	$6.04B	$1.46B	$645.0M	$3.62B
FY 2022	2022-04-29	$31.69B	$5.04B	$7.35B	$1.37B	$2.54B	$3.38B

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-07-31; shares outstanding as of 2026-08-28 from the cover page.

Federal contracts

The largest contract actions for Medtronic and its subsidiaries. JSON

12 contract actions on file for MDT: $903K obligated in the last 90 days and $4.0M in the last 12 months across 1 awarding agency. The largest was $2.8M from the Department of Veterans Affairs on 2026-06-25 (affera cardiac mapping ablation system - eo 14398). This covers the largest contract actions, not every award, and agencies report late.

Action date	Agency	Amount	Type	Description
2026-10-09	Department of Veterans AffairsDepartment of Veterans Affairs	$16	mod P00001delivery order	OTHERUSAspending
2026-10-08	Department of Veterans AffairsDepartment of Veterans Affairs	$143K	mod P00006definitive contract	O ARM IMAGING AND NAVIGATION XRAY SUPPORT OY1USAspending
2026-10-08	Department of Veterans AffairsDepartment of Veterans Affairs	$24K	new awardpurchase order	PERIPHERAL STENTS & BALLOONSUSAspending
2026-10-06	Department of Veterans AffairsDepartment of Veterans Affairs	$13K	new awardpurchase order	ANNUAL PREVENTATIVE MAINTENANCE FOR THE ECMO MACHINE "VITALFLOW"USAspending
2026-10-05	Department of Veterans AffairsDepartment of Veterans Affairs	$28K	new awardpurchase order	PROSTHETIC ORDERUSAspending
2026-10-05	Department of Veterans AffairsDepartment of Veterans Affairs	$21K	new awardpurchase order	EO 14938 SURGICAL IMPLANT PER VETERAN MEDICAL NEEDUSAspending
2026-10-02	Department of Veterans AffairsDepartment of Veterans Affairs	$21K	new awardpurchase order	SPINAL FUSIONUSAspending
2026-09-13	Department of Veterans AffairsDepartment of Veterans Affairs	$50K	new awardpurchase order	E014398 SURGICAL IMPLANTUSAspending
2026-08-15	Department of Veterans AffairsDepartment of Veterans Affairs	$63K	new awardpurchase order	EO 14398 MEDTRONICS SERVICESUSAspending
2026-07-21	Department of Veterans AffairsDepartment of Veterans Affairs	$540K	mod P00002purchase order	EXERCISE OPTION 1, EFFECTIVE 09/15/2026 - 09/14/2027USAspending
2026-06-25	Department of Veterans AffairsDepartment of Veterans Affairs	$2.8M	new awardpurchase order	AFFERA CARDIAC MAPPING ABLATION SYSTEM - EO 14398USAspending
2026-06-22	Department of Veterans AffairsDepartment of Veterans Affairs	$266K	new awarddelivery order	MEDTRONIC INPACT CATHETERSUSAspending

What this page is

Medtronic in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Medtronic (MDT), SEC CIK 1613103, listed on NYSE, classified by the SEC as electromedical & electrotherapeutic apparatus. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
Planned sales: SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-16.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-28.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials: SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-07-31.JSON and CSV
Federal contracts: USAspending.govSource: USAspending.gov.The largest contract actions each day, as agencies report them (up to 90 days late). Latest 2026-10-09.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-09-01.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-16.JSON and CSV
Company record: EDGAR filing index for CIK 1613103Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as electromedical & electrotherapeutic apparatus

Other company pages

Datasets

Frequently Asked Questions

How much of MDT is sold short?

39,974,230 shares were held short at the 2026-09-30 settlement, 2.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is MDT's daily short volume?

On 2026-10-09, 7,467,652 of the 10,172,858 MDT shares reported to FINRA were sold short, 73.4% of the day's reported volume. Short volume is a flow for one day, not a position.

Does MDT have fails to deliver?

The SEC's latest file shows 26,309 MDT shares failed to deliver at settlement 2026-09-11. Fails are reported per settlement date and published twice a month with a lag.

Are MDT insiders buying or selling?

Insiders at MDT reported 1 open-market sell worth $139K in the last 90 days and no open-market buys. Latest filing: KIIL HARRY SKIP (EVP & President Cardiovascular) on 2026-09-16.

Have MDT insiders filed to sell?

5 Form 144 notices on file for MDT worth $8.9M at the prices reported; 1 in the last 90 days worth $139K. Latest: KIIL HARRY SKIP filed on 2026-09-16 to sell 1,483 shares ($139K) from 2026-09-16.

Who owns 5% or more of MDT?

What did MDT report last quarter?

Which tracked 13F managers own MDT?

8 of the 30 tracked 13F managers held MDT shares at their latest filing, $1.64B in all. The largest: Ken Griffin's Citadel Advisors (5.4M shares, $420.4M), D. E. Shaw & Co. (4.4M shares, $344.0M), Cliff Asness's AQR Capital Management (3.3M shares, $258.1M), Two Sigma Investments (3.2M shares, $253.5M), Renaissance Technologies (3.2M shares, $247.8M), Izzy Englander's Millennium Management (918K shares, $71.9M). The table above lists all 8.

How much federal contract money did MDT receive?

$903K was obligated to Medtronic and its subsidiaries in the last 90 days and $4.0M in the last 12 months, counting the largest contract actions on USAspending, not every award. Obligations are not revenue; they are spent over each contract's life.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.